Search research articles
Contact Us
Filters
Showing results (141-150 of 286) with videos related to
Page
of 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert, Annika Röske, Silvia Niesporek, et al.
BMC Cancer
|
June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
Florian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
Oncology Reports
|
November 21, 2008
Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis
Aurelia Noske, Juliane Lena Lindenberg, Silvia Darb-Esfahani, et al.
Anticancer Research
|
August 19, 2007
Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor
Pawel Surowiak, Dawid Murawa, Verena Materna, et al.
Journal of Cancer Research and Clinical Oncology
|
December 25, 2008
Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro
Silvia Darb-Esfahani, Areeg Faggad, Aurelia Noske, et al.
International Journal of Cancer
|
July 24, 2012
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course
Sven Perner, Niels J Rupp, Martin Braun, et al.
Oncotarget
|
June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary site
Harald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 23, 2011
Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays
Jan Budczies, Wilko Weichert, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma
Carsten Denkert, Wilko Weichert, Klaus-Jürgen Winzer, et al.
Virchows Archiv : an International Journal of Pathology
|
March 24, 2005
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications
Wilko Weichert, Glen Kristiansen, Klaus-Jürgen Winzer, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 286) with videos related to
Sort By:
Page
of 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert, Annika Röske, Silvia Niesporek, et al.
BMC Cancer
|
June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
Florian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
Oncology Reports
|
November 21, 2008
Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis
Aurelia Noske, Juliane Lena Lindenberg, Silvia Darb-Esfahani, et al.
Anticancer Research
|
August 19, 2007
Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor
Pawel Surowiak, Dawid Murawa, Verena Materna, et al.
Journal of Cancer Research and Clinical Oncology
|
December 25, 2008
Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro
Silvia Darb-Esfahani, Areeg Faggad, Aurelia Noske, et al.
International Journal of Cancer
|
July 24, 2012
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course
Sven Perner, Niels J Rupp, Martin Braun, et al.
Oncotarget
|
June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary site
Harald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 23, 2011
Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays
Jan Budczies, Wilko Weichert, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma
Carsten Denkert, Wilko Weichert, Klaus-Jürgen Winzer, et al.
Virchows Archiv : an International Journal of Pathology
|
March 24, 2005
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications
Wilko Weichert, Glen Kristiansen, Klaus-Jürgen Winzer, et al.
Page
of 29